AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Journal article
Meeraus W. et al, (2024), J Infect, 88
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Journal article
Bedston S. et al, (2024), Lancet Reg Health Eur, 37